Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity
Frontiers in Cellular and Infection Microbiology · 18.11.2026 · 16
DOI: 10.3389/fcimb.2026.1977001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 18.11.2026. Verfasst von Qiang Liu und 6 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Porcine epidemic diarrhea virus (PEDV) causes severe diarrhea and high mortality in neonatal piglets, resulting in substantial economic losses for the global swine industry. In recent years, the PEDV GIIc genotype has emerged as the predominant circulating strain in China. Its antigenic characteristics differ from those of traditional vaccine strains, limiting the protective efficacy of existing vaccines. The spike (S) protein, a key structural protein responsible for inducing neutralizing antibodies and cellular immunity, serves as a prime candidate antigen for the development of PEDV subunit vaccines. In this study, a subunit vaccine was developed based on the S protein of the circulating PEDV GIIc strain; a CHO cell line stably expressing high levels of the S protein was established, enabling the production and purification of the recombinant S protein. Immunogenicity evaluations demonstrated that the S protein subunit vaccine elicited robust S protein-specific antibody responses and promoted antigen-specific cellular immune activation in mice. Furthermore, analysis of IgG subclasses showed that both IgG1 and IgG2a levels were elevated following immunization, and the IgG1/IgG2a ratio was greater than 1, suggesting a relative predominance of the IgG1 response. Compared to commercial inactivated vaccines, the two groups exhibited different immune response characteristics in terms of antigen-specific T-cell immunity, spleen cell proliferation, and the secretion of cytokines such as IFN-γ and IL-4. In conclusion, the S protein subunit vaccine is capable of eliciting both humoral and cellular immune responses, providing a candidate strategy and technical foundation for the development of novel vaccines targeting the currently prevalent PEDV GIIc strain. However, this study primarily evaluated the vaccine’s immunogenicity; its actual protective efficacy against PEDV infection still needs to be verified through further neutralization activity and challenge protection tests.
Zitieren
APA
Liu, Q., Chen, L., Tian, F., Liu, Z., Song, N., Gao, W., & Li, Y. (2026). Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1977001
Vancouver
Liu Q, Chen L, Tian F, Liu Z, Song N, Gao W, et al. Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1977001
BibTeX
@article{Liu2026,
author = {Liu, Qiang and Chen, Lu and Tian, Fangyuan and Liu, Zhuolin and Song, Nan and Gao, Weifeng and Li, Yong},
title = {Development of a CHO cell-produced PEDV GIIc S protein subunit vaccine candidate and evaluation of its immunogenicity},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1977001}
}
EUVIMED